Jci_page_head_homepage_01 Jci_page_head_homepage_02
Jeffery D. Molkentin
Published in Volume 111, Issue 9
J Clin Invest. 2003; 111(9):1275 doi:10.1172/JCI18389
Full text | PDF
Citation information

Total citations by year in CrossRef

Year: 2007 2006 2005 2004 Total
Citations: 2 3 1 3 9

Citations to this article in CrossRef (9)

Title and authors Publication Year
Gαq-PROTEIN CARBOXYL TERMINUS IMITATION POLYPEPTIDE GCIP-27 ATTENUATES CARDIAC HYPERTROPHY IN VITRO AND IN VIVO
Hai-Gang Zhang, Xiao-Hui Li, Jian-Zhi Zhou, Ya Liu, Yi Jia, Zhi-Bing Yuan
Clinical and Experimental Pharmacology and Physiology 2007
Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock*
Anthony S. McLean, Stephen J. Huang, Stephanie Hyams, Genie Poh, Marek Nalos, Rahul Pandit, Martin Balik, Ben Tang, Ian Seppelt
Critical Care Medicine 2007
Cardiovascular and metabolic effects of natriuretic peptides
Cedric Moro, Michel Berlan
Fundam Clin Pharmacol 2006
Role of cyclic GMP and calcineurin in homologous and heterologous desensitization of natriuretic peptide receptor-A
Yann Fortin, André De Léan
Can. J. Physiol. Pharmacol. 2006
Maintaining serum response factor activity in the older heart equal to that of the young adult is associated with better cardiac response to isoproterenol stress
G. Azhar, X. Zhang, S. Wang, Y. Zhong, C. M. Quick, J. Y. Wei
Basic Res Cardiol 2006
Natriuretski peptidi u kliničkoj praksi
Radomir Matunovic, Aleksandar Stojanovic, Milorad Damjanovic
VSP 2005
B-Type Natriuretic Peptide and Its Clinical Implications in Heart Failure
Peter A. McCullough
Amer Heart Hosp J 2004
Nitric oxide and the enigma of cardiac hypertrophy
Tibor Kempf, Kai C. Wollert
Bioessays 2004
Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
Thomas J. Wang, Martin G. Larson, Daniel Levy, Emelia J. Benjamin, Eric P. Leip, Torbjorn Omland, Philip A. Wolf, Ramachandran S. Vasan
N Engl J Med 2004